Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage <scp>IV</scp> non‐small cell lung cancer
The volume of stage IV NSCLC primary tumor can affect the survival of patients. Appropriate treatment methods can be opted by considering the volume of tumors to extend patients' lifetime to the utmost.
Authors
- Wengang Yang
- Shengfa Su (ORCID: https://orcid.org/0000-0002-6429-0081)
- Shimei Fu
- Xiaxia Chen (ORCID: https://orcid.org/0000-0002-6251-888X)
- Yichao Geng (ORCID: https://orcid.org/0000-0001-5157-4571)
- Lan Luo (ORCID: https://orcid.org/0000-0001-6624-9755)
- Dongdong Cao (ORCID: https://orcid.org/0000-0001-5932-9052)
- Wei Zhang
- Bing Lü (ORCID: https://orcid.org/0000-0001-9385-3931)
- Weiwei Ouyang
- Qingsong Li (ORCID: https://orcid.org/0000-0002-6895-3495)
Institutions
- Guiyang Medical University (CN)
- Sun Yat-sen University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70221
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42